Summary

JTEC Corporation is a company engaged in the development, manufacturing, and sales of optical products and bio-related equipment, with particular expertise in ultra-high-precision X-ray nanofocusing mirrors and automated cell culture systems. Established in 1993, the company operates under the management philosophy of “creating one-of-a-kind technologies to develop products that contribute broadly to society.” Its core products are used at synchrotron radiation facilities and X-ray free-electron laser (XFEL) facilities both in Japan and overseas, where they have earned strong recognition in scientific research settings.

The company’s operations are divided into three segments: the Optical Business, the Life Science & Equipment Development Business, and Other Businesses. The Optical Business accounts for the majority of total sales. Demand in the Life Science Business has surged due to the impact of COVID-19, with particularly strong performance in automated cell culture systems.

For the fiscal year ended June 2023, net sales reached ¥2,010 million, representing 105.3% year-on-year growth. However, for fiscal year 2024, sales are projected to decline slightly to ¥1,926 million. Operating profit is expected to decrease from ¥286 million to ¥114 million, mainly due to rising selling, general and administrative (SG&A) expenses.

Under its medium-term management plan, “Innovation2030,” the company aims to achieve net sales of ¥2,655 million and operating profit of ¥278 million in fiscal 2026, with growth expected particularly in the Optical and Life Science businesses. JTEC seeks sustainable growth while actively addressing environmental considerations and social contributions, and it is required to build a business model aligned with ESG factors. For investors, technological innovation and flexible responses to market needs will be key drivers of future growth. Through partnerships with research and medical institutions, the company aims to further expand its market presence and pursue sustainable growth.

1. Consolidated Financial Overview for the Fiscal Year Ended June 2023

For the cumulative fiscal year ended June 2023 (July 2022–June 2023), JTEC Corporation reported consolidated net sales of ¥2,010 million, representing a 105.3% increase year on year. The core Optical Business performed steadily, driven in particular by increased demand for high-precision X-ray mirrors for synchrotron radiation facilities.

However, operating profit declined from ¥286 million to ¥114 million, and the operating margin fell from 14.2% to 5.9%. This decline was primarily attributable to higher SG&A expenses, especially due to workforce expansion and costs associated with new product development.

In the Life Science Business, sales of the automated cell culture system “CellMeister” were strong, although overall profitability was pressured. On the balance sheet, total assets stood at ¥3,465 million, and the current ratio remained healthy at 213%. However, the increase in accounts receivable has become a concern. In the cash flow statement, operating cash flow declined to ¥210 million, mainly due to increases in accounts receivable and inventories.

Going forward, shortening the collection period for receivables and improving operational efficiency will be necessary. Overall, while JTEC continues to maintain a growth trend, it has entered a phase requiring short-term performance adjustments, making a review of management strategy and stricter cost control key priorities.

2.  Earnings Forecast for the Fiscal Year Ending June 2024

For the fiscal year ending June 2024, net sales are projected at ¥1,926 million and operating profit at ¥114 million, indicating a slight decline from the previous year. In particular, large-scale projects in the Optical Business are expected to impact results, leading to a decrease in sales from ¥2,010 million in the prior year.

Nevertheless, demand for life science-related products remains strong, and the company maintains a stable customer base. Operating profit is expected to decline from ¥286 million to ¥114 million, with the operating margin falling from 14.2% to 5.9%.

As a result, the company recognizes the need for short-term performance adjustments and is being pressed to restructure its strategy. Increased SG&A expenses continue to weigh on profitability, necessitating a review of fixed costs and improved operational efficiency.

The company has formulated a medium-term management plan targeting net sales of ¥2,655 million and operating profit of ¥278 million in fiscal 2026. Growth in both the Optical and Life Science businesses is anticipated. In particular, expanding demand at synchrotron radiation facilities and developing new products related to automated cell culture technology are key themes. Leveraging its competitive strengths in an increasingly competitive market and strengthening its customer base will be critical.

As the company strives for sustainable growth, it will focus on technological innovation and new business development, while pursuing strategies designed to maintain investor confidence. Overall, JTEC Corporation intends to move beyond short-term adjustments and advance initiatives aimed at long-term growth.

3. Medium- to Long-Term Growth Strategy

JTEC Corporation has formulated its medium-term management plan, “Innovation2030,” covering the period from 2026 to 2028, with the goal of achieving sustainable growth. The plan sets specific targets for fiscal 2026: net sales of ¥2,655 million and operating profit of ¥278 million, with particular emphasis on expanding the Optical and Life Science businesses.

To respond to changes in the market environment, stabilizing existing operations while launching new businesses is an urgent priority, requiring a careful balance between the two.

Key initiatives include improving the precision of high-accuracy mirrors for synchrotron radiation facilities and developing new products. The company plans to strengthen collaboration with Osaka University to advance new product development based on nanofabrication technologies.

In the Life Science field, investments are planned in automated cell culture systems and related peripheral equipment, with product lines targeting treatments for cerebral infarction and dementia expected to play a significant role.

Risk management is also a critical component, as the company must respond flexibly to market volatility, rapid technological innovation, and changes in the competitive landscape. In particular, careful risk assessment and countermeasures are required to address uncertainties associated with launching new businesses.

Furthermore, to strengthen human capital and improve operational efficiency, the company is focusing on introducing a role-based grading system and recruiting and developing personnel with specialized expertise. These initiatives aim to enhance overall productivity and establish a foundation for sustained growth.

For investors, the execution of these plans serves as a key indicator of the company’s growth potential. Future expansion in the Asian market and the acquisition of new business opportunities in the life sciences sector are expected to accelerate growth. How effectively these strategies are implemented and translated into tangible results will be closely watched.

JTEC Corporation is committed to pursuing sustainable growth through technological innovation and flexible responsiveness to customer needs.

・ In the fiscal year ended June 2023, net sales increased 105.3% year on year, while operating profit declined, highlighting the need for strategic review and cost management.

・ For fiscal year 2024, net sales of ¥1,926 million and operating profit of ¥114 million are forecast, with a year-on-year decline expected due in part to large-scale projects in the Optical Business, prompting short-term performance adjustments and strategic restructuring.

・ Under its medium-term management plan “Innovation2030,” JTEC Corporation aims for net sales of ¥2,655 million and operating profit of ¥278 million in fiscal 2026, prioritizing growth in the Optical and Life Science businesses while stabilizing existing operations and launching new ones.

Business Overview

1. Corporate Introduction to JTEC Corporation

JTEC Corporation (hereinafter “JTEC”) is a company primarily engaged in the development, manufacturing, and sales of optical products and bio-related equipment. It was founded in 1993 by President Takashi Tsumura and operates under the corporate philosophy of “creating one-of-a-kind technologies to develop products that contribute broadly to society.”

The company specializes in ultra-high-precision X-ray nanofocusing mirrors and automated cell culture systems, offering product lines that contribute to technological innovation in research institutions and the medical field. Through this focus, JTEC has established a position of overwhelming competitive advantage in specific niche markets.

Its flagship high-precision X-ray mirrors are used at synchrotron radiation facilities and X-ray free-electron laser facilities both in Japan and overseas, where they are highly regarded in scientific research environments. In the life sciences segment, the company markets the automated cell culture system “CellMeister” and the three-dimensional floating culture technology “CELLFLOAT,” addressing growing needs in regenerative medicine. Its primary customers include public research institutions such as RIKEN and Osaka University, enabling the company to maintain a stable customer base.

2. Details of Core Business Segments

JTEC operates mainly through three business segments: the Optical Business, the Life Science & Equipment Development Business, and Other Businesses.

2.1 Optical Business
The Optical Business is the company’s core segment, accounting for the majority of total sales. It plans and manufactures high-precision X-ray mirrors and focusing systems. These mirrors are essential components at synchrotron radiation facilities, and demand is expected from research institutions worldwide.

By leveraging advanced nanofabrication technologies, JTEC delivers products capable of meeting highly demanding customer specifications with exceptional quality. Furthermore, through mid- to long-term contracts both domestically and internationally, the company secures stable revenue streams.

2.2 Life Science & Equipment Development Business
In the Life Science Business, JTEC introduces new technologies such as automated cell culture systems to meet market demand in regenerative medicine and biotechnology. Demand for automation equipment surged particularly during the COVID-19 pandemic, leading to increased transactions with medical institutions and pharmaceutical companies.

As new product development progresses, continuously adapting to changing market conditions remains a critical challenge for this segment.

2.3 Other Businesses
The Other Businesses segment includes Denshi Kagaku Co., Ltd., which manufactures and sells various scientific instruments. In particular, thermal desorption spectroscopy (TDS) systems are experiencing growing demand in the semiconductor field, and the company plans to introduce new products expected to drive further growth. This segment also serves as an important pillar contributing to overall profitability.

3. Business Model and Customer Base

JTEC’s business model emphasizes the provision of customized, made-to-order products tailored to customer needs. Through partnerships with research and medical institutions, the company supplies advanced products and builds strong relationships of trust, thereby expanding repeat business. Its ability to respond quickly to customer-specific customization requests strengthens its competitive advantage.

Moreover, research and development through industry–academia collaboration forms the foundation of its growth. By leveraging academic partnerships, JTEC has established a system that rapidly commercializes cutting-edge scientific knowledge and brings it to market. This approach enables the company to build unique capabilities that competitors cannot easily replicate.

4. Growth Strategy and Future Outlook

JTEC focuses not only on short-term growth but also on technological innovation and new business development under its medium-term management plan. In particular, the company aims to achieve net sales of ¥2,655 million and operating profit of ¥278 million by fiscal 2026, and preparations toward these goals are underway. Expanding into new markets and improving profitability through product development are pressing priorities.

Key future themes include expanding demand at synchrotron radiation facilities, particularly in Asia, and developing new products related to automated cell culture technologies. In an increasingly competitive market, leveraging the company’s strengths and reinforcing its customer base will be essential.

5. Sustainability and CSR Initiatives

JTEC is also committed to realizing a sustainable society and actively engages in environmental and social contribution initiatives. In product development, the company pursues environmentally conscious design and manufacturing methods and seeks to build a business model aligned with ESG (Environmental, Social, and Governance) principles.

Through these efforts, JTEC aims to further enhance social trust and increase corporate value.

Overall, JTEC pursues sustainable growth by leveraging its unique high-performance products and expanding its market presence through partnerships with research and medical institutions. Technological innovation and flexible responsiveness to customer needs are expected to be key drivers of future growth.

The overall business profile of JTEC Corporation is expected to expand further, supported by its robust business model, competitive market position, and commitment to sustainability. The next chapter will focus on financial performance trends and examine in greater detail the growth potential reflected in specific numerical results.

Performance Trends

1. Recent Performance Overview

JTEC Corporation designs and develops high-precision optical products and bio-related equipment, with particular strengths in nanofabrication technology. In recent years, its technological superiority has been reflected in its financial results, achieving growth for three consecutive fiscal periods.

In particular, for the fiscal year ended June 2023, net sales reached ¥2,010 million, representing 105.3% growth from ¥1,908 million in the previous year. However, the forecast for fiscal 2024 projects a slight decline to ¥1,926 million, mainly due to the project-based nature of large-scale contracts in the Optical Business.

Operating profit declined from ¥307 million in 2022 to ¥286 million in 2023, though it remained at a stable level overall. This stability was supported in part by strong performance in life science-related products, including the automated cell culture system “CellMeister.” However, operating profit for fiscal 2024 is projected to fall further to ¥114 million, with the operating margin declining from 14.2% to 5.9%. As a result, the company faces the need for short-term performance adjustments and strategic restructuring.

2. Analysis of the Income Statement

A closer examination of JTEC’s income statement shows that net sales reached ¥2,010 million in fiscal 2023, up 105.3% year on year. However, operating profit is expected to decline from ¥286 million to ¥114 million, largely due to increased selling, general and administrative (SG&A) expenses, which totaled ¥1,065 million.

SG&A expenses are essential for business operations, primarily consisting of sales activities and research and development costs. Consequently, the operating margin declined from 14.2% to 5.9%.

The increase in SG&A expenses reflects workforce expansion and the necessity of developing new products—investments that can be regarded as justified efforts to strengthen competitiveness. Nevertheless, to offset the negative impact of these rising costs on operating profit, further revenue growth and strategic cost management will be crucial. Going forward, reviewing fixed costs and improving operational efficiency will be necessary to enhance profitability.

3. Analysis of the Balance Sheet

As of the fiscal year ended June 2023, total assets stood at ¥3,465 million. Both current and non-current assets increased, while the rise in liabilities has emerged as a potential concern. Current assets totaled ¥1,677 million and non-current assets ¥1,788 million, with a current ratio of 213%, indicating a sound level of short-term solvency and overall financial stability.

Accounts receivable increased to ¥579 million, warranting careful attention to cash flow management. Delays in collecting receivables could negatively affect liquidity, making robust receivables management essential. Maintaining an appropriate balance between assets and liabilities and ensuring efficient asset turnover will be directly linked to the company’s financial health, underscoring the importance of future strategic measures.

4. Analysis of the Cash Flow Statement

The cash flow statement highlights the characteristics of operating, investing, and financing activities. For fiscal 2023, operating cash flow decreased to ¥210 million from ¥284 million in the previous year. This decline is primarily attributable to increases in accounts receivable and inventories.

Going forward, strategies to shorten the collection period for receivables will be necessary to improve cash flow.

In investing activities, expenditures for the acquisition of fixed assets were recorded. Such investments are necessary for future growth, particularly capital expenditures aimed at improving efficiency, which may contribute to mid-term profit growth.

In financing activities, repayments of long-term borrowings continued, indicating the need to reassess financing strategies. The company must strike a balance between building stable cash flows and securing funds for future investment opportunities.

5. Analysis of Key Financial Indicators

Key performance indicators such as ROE and ROA provide important insights into JTEC’s financial condition. In fiscal 2022, ROE was approximately 12.5%, declining to around 9.9% in fiscal 2023. Similarly, ROA fell from 7.5% to 6.2%. These declines reflect reduced profitability and highlight the need for measures to support sustainable growth.

EBITDA reached ¥452 million, maintaining relative stability compared with the previous year. However, the company’s ability to adapt to market fluctuations and improve internal management efficiency will be increasingly scrutinized.

These indicators suggest the company’s growth potential and management soundness, emphasizing the importance of revising strategic approaches in response to changing demand conditions. Achieving sustainable growth will require comprehensive management of these financial metrics.

Regardless of future developments, analysis based on financial indicators will influence strategic decision-making. Investors should not only track short-term performance fluctuations but also evaluate long-term growth strategies when making investment decisions.

Overall, while JTEC Corporation has maintained a growth trajectory in recent years, it has entered a phase requiring short-term adjustments. Taking into account market conditions and intensifying competition, clarifying management strategy is expected to contribute to sustainable growth. To enhance corporate value, robust risk management and flexible management policies will be essential.

Medium-Term Management Plan / Growth Strategy

1. Management Environment and Key Issues

JTEC Corporation has formulated a medium-term management plan covering the period from 2026 to 2028, aiming to achieve sustainable growth. This plan is grounded in the company’s corporate philosophy of “contributing broadly to society through one-of-a-kind technologies,” placing product development driven by scientific and technological innovation at its core.

In the fiscal year ending June 2025, consolidated results fell short of expectations, creating a challenging business environment. However, the company positions this experience as an important milestone toward its next phase of growth and has incorporated these lessons into the new plan.

Rapid technological innovation and changes in the market environment exert significant influence on corporate performance. Amid intensifying competition, clear strategic direction is required. In addition to stabilizing existing businesses, launching new ventures has become an urgent priority. Securing a sustainable growth trajectory requires a careful balance between these two objectives. For investors, understanding this management backdrop is essential for making informed decisions.

2. Overall Framework and Targets of the Medium-Term Plan

JTEC has branded its medium-term vision as “Innovation2030,” setting specific numerical targets of ¥2,655 million in net sales and ¥278 million in operating profit for fiscal 2026. The plan reflects an intention to increase net sales by 137.9% and operating profit by 244.9% compared with the previous fiscal year.

Growth is expected to be driven primarily by the Optical Business and the Life Science Business, supported by rising international demand in the synchrotron radiation field.

Achieving these targets will require strengthening organizational structures and human capital, as well as improving operational efficiency. Progress will be monitored regularly through the establishment of KPIs in each business division, with strategies reviewed and revised as necessary. For investors, clearly defined numerical goals serve as an important indicator of the feasibility of the company’s growth strategy.

3. Key Initiatives and Investment Policy

Under its medium-term management plan, JTEC has announced a policy of strengthening investment particularly in the Optical Business and the Life Science & Equipment Development Business. This includes the introduction of new manufacturing equipment and advanced technologies, with particular emphasis on improving the precision of mirrors for synchrotron radiation facilities and developing new products.

For example, the company plans to enhance collaboration with Osaka University to promote new product development based on nanofabrication technologies.

In the life sciences field, investments are planned in automated cell culture systems and related peripheral equipment, with product lines targeting treatments for cerebral infarction and dementia expected to be particularly promising. Additionally, as part of new R&D initiatives, the company is focusing on the development of optical components for semiconductor-related and space industry applications, thereby promoting business diversification.

These initiatives are intended to accelerate growth across each segment and build comparative advantages over the long term. For investors, it is important to evaluate whether these priority measures can serve as core drivers of sustainable growth.

4. Approach to Risk Factors

Risk management is a key component of the medium-term management plan. The company faces risks including market fluctuations, the pace of technological innovation, and changes in the competitive landscape, all of which may directly impact performance.

In particular, uncertainties associated with launching new businesses are significant, and achieving the plan’s targets will require careful risk assessment and appropriate countermeasures.

Given that the business model is susceptible to economic cycles, flexibility in responding to macroeconomic fluctuations is also essential. From an investor’s perspective, understanding how these risk factors may influence corporate growth is crucial for capital allocation decisions. It is important to confirm whether the company has implemented concrete risk management measures and established preparedness for potential crises.

5. Execution Structure and Human Capital

Successful implementation of the medium-term management plan requires a robust execution framework and strengthened human capital. JTEC aims to enhance employee motivation and organizational performance by introducing a role-based grading system that supports clear career paths.

Recruiting and developing personnel with specialized expertise in specific fields is also identified as a key initiative. Improving overall productivity through employee engagement forms the foundation for sustainable growth.

Such efforts contribute to strengthening corporate culture and improving operational efficiency. With an effective execution structure in place, improved corporate performance can be expected, creating an environment in which investors may anticipate stronger returns. Human capital enhancement directly underpins the company’s competitive strength and is therefore likely to influence future performance significantly.

6. Evaluation of Outcomes and Expected Effects

The medium-term management plan incorporates periodic evaluations of performance outcomes. Progress is assessed using specific indicators such as revenue growth and improvements in profit margins, with regular reviews conducted.

In particular, leveraging technological development and deep insights into market needs to introduce new products is expected to expand earnings. Through these initiatives, the company aims to improve its overall financial condition and establish a stable foundation for long-term growth.

Moreover, enhanced risk management and strengthened human capital are expected to contribute to long-term corporate value creation. Investors are encouraged to assess both the tangible results and anticipated benefits of these initiatives when evaluating the company’s growth potential and making investment decisions.

7. Outlook from an Investor Perspective

The medium-term management plan and growth strategy of JTEC Corporation provide an important framework for achieving sustainable corporate growth. For investors, these plans represent clear indicators of the company’s growth potential, drawing attention to their effective execution.

Strategic measures aimed at strengthening international competitiveness and enhancing risk management are also noteworthy as mechanisms for securing sustainable growth.

Looking ahead, expansion of demand in Asian markets and the acquisition of new business opportunities in the life sciences field are expected to accelerate growth. How effectively these strategies are implemented and translated into results will be of significant interest to investors.

Investors should closely monitor how initiatives based on the medium-term management plan adapt to evolving market needs and enhance corporate value. As the plan is executed, a supportive stance toward the company’s growth initiatives will also be essential.

News & Topics

1. Formulation of the Medium-Term Management Plan and Growth Strategy

JTEC Corporation has formulated a medium-term management plan beginning in the fiscal year ending June 2026, clearly outlining its strategy for corporate growth. Based on its philosophy of “contributing broadly to society through one-of-a-kind technologies,” the plan aims to implement concrete measures to generate scientific and technological innovation.

Under the plan covering fiscal years 2026 through 2028, the company has set revenue targets of ¥2,655 million, ¥3,200 million, and ¥4,000 million, respectively. In particular, the Optical Business is expected to grow to ¥2,200 million in revenue. Achieving these targets will require strengthened product development capabilities and increased order acquisition.

From an expert perspective, a medium-term management plan can serve as an indispensable tool for corporate growth. Clearly defined goals contribute to appropriate resource allocation and enhanced employee motivation, both of which are key success factors. Focused investment in high-growth segments will also be necessary to establish a sustainable earnings model.

From an investor standpoint, the plan signals an aggressive growth strategy and raises expectations for improved profitability. However, intensifying competition and changes in the market environment remain concerns, making close monitoring of progress and rigorous risk management essential.

2. Market Opportunities in the Optical Business

JTEC’s Optical Business primarily designs, manufactures, and sells high-precision mirrors for synchrotron radiation facilities, with particularly strong demand emerging in Asia. Market analysis indicates that as new synchrotron facilities are constructed, demand for enhanced equipment performance is increasing, requiring the company to maintain its technological superiority.

For fiscal 2028, the company has set a revenue target of ¥2,200 million for the Optical Business. If achieved, this would significantly contribute to overall corporate growth.

Growth in this segment is supported by investments in synchrotron facility infrastructure. Increased research budgets at universities and public research institutions have helped JTEC expand order intake. Experts suggest that further market development in Asia could accelerate future growth. In particular, strengthening relationships with research institutions in China and South Korea may help secure orders and foster new technological development.

From an investor’s perspective, the Optical Business is expected to serve as a sustainable source of earnings, and strategic investments to maintain competitive advantage are crucial. While risks include competitor activity and price competition, appropriate countermeasures could support long-term growth.

3. Accelerating Growth in the Life Science & Equipment Development Business

The Life Science & Equipment Development Business is one of JTEC’s fastest-growing segments. Demand for automated cell culture systems and drug discovery screening has increased, particularly due to the impact of COVID-19, which has heightened the need for automation and improved working environments.

In response, JTEC plans to accelerate the development of new products, with offerings such as “CellMeister” and “MakCell” attracting market attention.

Experts believe this segment has strong growth potential, particularly with expansion into regenerative medicine and the broader medical device market. Success in this area will depend not only on product launches but also on the outcomes of collaborative research with customers. For example, joint development of new technologies with Tokyo Medical and Dental University is underway, and successful results could contribute to expanding the customer base.

For investors, the potential of this segment is significant, though careful attention must be paid to competitors and the rapid pace of technological innovation. Assessing whether growth in this field will translate into sustainable profitability is also critical.

4. Expansion of the Denshi Kagaku Business and Strengthening Profitability

The subsidiary Denshi Kagaku Co., Ltd. focuses primarily on thermal desorption spectroscopy (TDS) systems, with steady demand from the semiconductor industry driving revenue growth.

For the fiscal year ending June 2026, revenue for this segment is projected at ¥471 million, representing a year-on-year increase of 108.2%. Development of a new hydrogen analysis system is also underway, which is expected to contribute to the acquisition of new customers.

Experts suggest that strengthening relationships with semiconductor manufacturers will be key to growth in this segment. Introducing enhanced TDS systems with new functionalities and developing analytical instruments suited to a hydrogen-based society could improve competitiveness. The segment is expected not only to deepen its presence in existing markets but also to pursue strategic expansion into new markets.

From an investor’s perspective, the growth of the Denshi Kagaku Business is likely to contribute to overall earnings, particularly if product development successfully aligns with technological innovation and market demand. Strengthened risk management and a flexible approach to capturing new business opportunities will therefore be essential.

5. Changes in the Business Environment and Risk Management

The global economic environment has become increasingly unstable, with factors such as U.S.–China trade tensions, exchange rate fluctuations, and the continuing impact of COVID-19 affecting corporate operations. JTEC must strengthen its risk management framework to address these external factors.

Because customer orders are typically handled on an individual contract basis, fluctuations in the period from order receipt to revenue recognition pose a risk. To mitigate this, the company needs to review order planning processes and strengthen communication with customers.

Looking ahead, JTEC has launched its long-term strategy “Innovation2030,” focusing on building a foundation for sustained growth. Enhancing human capital, promoting digitalization, and strengthening investor relations (IR) activities are key components supporting sustainable development.

For investors, maintaining awareness of management risks while evaluating the leadership’s responsiveness and commitment to transformation will be critical, as these factors are likely to influence long-term corporate value.

Through the development of new business models and growth strategies, JTEC is advancing toward sustainable growth. Future performance will depend on how effectively the company responds to emerging market needs and maintains and enhances its competitive strength—ultimately determining its ability to increase corporate value.

Company Overview

1. Basic Corporate Information

JTEC Corporation (hereinafter “JTEC”) is a Japanese technology company specializing in optical products and bio-related equipment. It was founded in December 1993 by its Representative Director and President, Takashi Tsumura. The company is headquartered at 2-5-38 Saito Yamabuki, Ibaraki City, Osaka Prefecture, Japan, and operates a core business focused on ultra-high-precision X-ray mirrors for advanced synchrotron radiation facilities and X-ray free-electron laser (XFEL) facilities in Japan and overseas.

As of the end of June 2025, JTEC has a capital of ¥847,148 thousand and employs 75 people. Its corporate philosophy is “to create products through one-of-a-kind technologies that do not yet exist in the world and contribute broadly to society,” promoting product development driven by scientific and technological innovation.

The company’s primary business segments are the Optical Business and the Life Science & Equipment Development Business, both of which provide high-quality products utilizing advanced technologies. These technological capabilities have supported the expansion of market share domestically and internationally, contributing to enhanced global competitiveness.

From an investor’s perspective, technological innovation and rapid responsiveness to market needs are key drivers of future growth. The company’s forward-looking stance strengthens its competitiveness in advanced technological fields and supports sustainable growth.

2. History and Major Milestones

JTEC’s history reflects continuous technological innovation and adaptation to market needs since its founding in 1993. In 1994, the company successfully developed an automated cell culture system, laying the foundation for growth in biotechnology-related fields.

In 2005, through joint development with RIKEN, JTEC commercialized an X-ray nanofocusing mirror. This product, known as “OsakaMirror,” gained global recognition for its technological excellence.

In 2016, the company changed its name to JTEC Corporation. In 2018, it was listed on the Tokyo Stock Exchange Mothers market. In 2020, it was transferred to the First Section of the Tokyo Stock Exchange, and in 2022, it transitioned to the Prime Market, further enhancing its credibility in the capital markets.

In 2023, JTEC established a joint research division at Osaka University, strengthening its contribution to scientific and technological advancement.

These milestones demonstrate not only corporate growth but also a commitment to advancing innovation across the industry. Investors should regard this track record as an important indicator of the company’s path toward sustainable growth, which may influence future investment decisions.

3. Organizational Structure and Key Management

JTEC’s organizational structure emphasizes expertise in product development. The management team, led by President Takashi Tsumura, consists of professionals with extensive experience in technology and corporate administration. President Tsumura leverages his deep understanding of industry trends and foresight to guide the company’s strategic direction. His leadership supports both product innovation and the strengthening of competitive positioning within the industry.

The board includes Masahiko Kanaoka (Head of Sales), Tetsuya Hibiya (Head of Administration), and Masanori Tsujioka (Head of Technology), with each department functioning as a specialized team. This structure enables a cross-functional, project-based approach that enhances operational efficiency.

The company also places strong emphasis on talent development to invigorate the organization as a whole. Identifying and nurturing the next generation of innovators is considered a key factor underpinning future growth.

From an investor’s standpoint, the expertise of the management team and the robustness of the organizational structure are important elements that enhance confidence in the company’s future prospects.

4. Business Activities and Structure

JTEC operates through three main business segments.

First, in the Optical Business, the company designs, manufactures, and sells ultra-high-precision X-ray mirrors for synchrotron radiation and XFEL facilities. A representative product is “OsakaMirror,” which is highly regarded for its innovative focusing performance, particularly in the hard X-ray region. This technological advancement has earned strong support from research institutions worldwide and contributed to increased market share.

Second, in the Life Science & Equipment Development Business, JTEC develops products specializing in automated cell culture systems and regenerative medicine-related technologies. In particular, the company is advancing applications for induced pluripotent stem (iPS) cells and other regenerative medicine technologies, with promising market prospects.

Finally, in collaboration with Denshi Kagaku Co., Ltd., JTEC is expanding into related new business areas. The diversification of these businesses contributes to a broader revenue base and successful risk dispersion across multiple markets.

From an investor’s perspective, business diversification is expected to promote sustainable growth and improve long-term profitability.

5. ESG and Sustainability Initiatives

JTEC places strong emphasis on Environmental, Social, and Governance (ESG) initiatives and demonstrates a clear commitment to achieving a sustainable society. In particular, reducing environmental impact in manufacturing processes and promoting efficient resource utilization are fundamental policies. These efforts are expected to generate positive environmental and societal impacts.

As part of its social responsibility initiatives, the company actively promotes industry–academia collaboration and regional contribution activities. The establishment of a joint research division with Osaka University represents a significant measure that strengthens research and development while contributing to the local community.

These initiatives provide a foundation not only for enhancing long-term corporate value but also for building trust with stakeholders.

For investors, proactive engagement in ESG initiatives contributes to value preservation and enhancement, making it important to closely monitor future developments. The company’s commitment to sustainable growth will likely serve as a key evaluation criterion in investment decision-making.

In summary, JTEC Corporation presents itself as a company that successfully balances advanced technological capabilities with social responsibility. Investors are encouraged to evaluate the transparency of its corporate activities while maintaining expectations for its future initiatives and growth strategies.

Shareholder Returns

1. Dividend Policy and History

JTEC Corporation (hereinafter “the Company”) recognizes the importance of shareholder returns while maintaining a basic policy of securing the internal reserves necessary for management and providing stable dividends. Its dividend policy may be reviewed in accordance with the business environment and growth strategy, reflecting a flexible approach aimed at meeting shareholder expectations.

In the financial results announced in March 2023, although the Company recorded net income, it chose not to pay a dividend in order to strengthen its management foundation and focus on future business development. This decision reflects a priority on sustainable growth and long-term corporate value creation. While the Company had historically provided stable dividends, the recent decision to suspend dividends is viewed as a prudent response to strategic shifts and changes in the market environment.

By emphasizing the strengthening of internal reserves, the Company aims to enhance competitiveness and increase corporate value through investment in new businesses. Accordingly, its dividend policy is positioned not merely as profit distribution but as a strategic initiative contributing to the Company’s future. This flexible stance in response to management strategy and market changes leaves room for expectations of a future resumption of dividends.

2. Share Repurchases and Their Impact

At present, JTEC Corporation has not implemented share repurchases; however, such measures may be considered in the future as part of its growth strategy. Share buybacks function as a means of shareholder return, stock price stabilization, and enhancing share scarcity by repurchasing outstanding shares from the market.

The rationale behind share repurchases often includes strengthening shareholder confidence and enhancing returns. By reducing the number of shares outstanding, supply–demand dynamics may improve, potentially supporting stock price appreciation. Additionally, from the perspective of improving capital efficiency, share buybacks can contribute to profitability and shareholder returns.

That said, careful judgment is required when acquiring treasury shares. There is a risk that capital constraints resulting from buybacks could limit growth opportunities, making it essential to strike an appropriate balance. Although no specific buyback policy has been announced at this time, implementation may be considered depending on future market conditions and management strategy, with the potential to enhance long-term shareholder value.

Overall, share repurchases represent an important element of shareholder return policy and can play a significant role in corporate growth strategy. However, decisions must be made with due consideration for the balance between internal reserves and investment opportunities.

3. Total Payout Ratio and Alignment with Financial Strategy

JTEC Corporation’s total payout ratio is managed in alignment with its current dividend policy and overall financial strategy. The total payout ratio is a key indicator showing the proportion of earnings returned to shareholders, reflecting corporate credibility and commitment to shareholders.

While maintaining a policy of stable dividends, the Company places emphasis on internal reserves and aims for capital allocation that does not forgo growth opportunities. Fluctuations in dividend policy reflect a flexible response to changes in the business and market environment, signaling to investors that the Company prioritizes not only short-term profit distribution but also long-term corporate growth.

In particular, pursuing dividend stability while considering sustainable growth is an important factor for shareholders. By implementing a dividend policy grounded in a long-term perspective, the Company enhances overall credibility and meets investor expectations.

In this way, JTEC Corporation’s shareholder return policy maintains consistency with its financial strategy while fostering expectations for sustainable growth. Continued adherence to this policy is expected to further strengthen the stability of shareholder returns.

4. Medium- to Long-Term Policy and Sustainability

JTEC Corporation approaches shareholder return policy from a medium- to long-term perspective and has articulated a strategy aimed at sustainable growth. By enhancing internal reserves, the Company seeks to make proactive investments in high-growth markets and strengthen its business foundation.

The decision to suspend dividends reflects a priority on investments that contribute to future growth rather than short-term profit distribution. This approach is important in building a company resilient to economic uncertainty and changing market conditions. From a shareholder perspective, investing in a company with prospects for sustainable growth can be an effective strategy for achieving long-term returns.

A policy focused on sustainable growth is essential in increasingly competitive industries and supports the Company’s goal of enhancing corporate value as a means of returning value to shareholders. As the Company grows, the potential resumption of dividends represents a positive factor for investors with a medium- to long-term outlook.

Thus, JTEC Corporation’s medium- to long-term policy is closely linked to its shareholder return strategy and aims to enhance corporate value while emphasizing sustainability, ultimately creating the potential for substantial shareholder returns.

5. Approach to Communication with Investors

In JTEC Corporation’s shareholder return strategy, its approach to communication with investors is a crucial element. Through transparent disclosure of information, the Company seeks to strengthen relationships with shareholders and build trust.

The Company must regularly communicate its dividend policy and growth strategy to meet shareholder expectations. In particular, explanations regarding revisions or decisions related to dividend policy in response to changes in the management environment are essential for deepening trust.

From the shareholder perspective, it is also important to gain a detailed understanding of the Company’s growth strategy and management policies. Rather than focusing solely on stable dividends, understanding initiatives that promote sustainable corporate growth is meaningful when considering long-term returns.

Smooth communication between the Company and its shareholders helps meet expectations and enhance corporate value. Investors should therefore understand the Company’s stance and maintain expectations regarding future shareholder returns.

JTEC Corporation is expected to continue implementing its shareholder return policy while contributing to overall corporate growth. For investors, this approach provides reassurance and represents an important factor in long-term investment decisions.

Through its policies and track record regarding shareholder returns, shareholders can maintain expectations for future profit distribution and benefit from the Company’s sustainable growth.

Looking ahead, it is anticipated that JTEC Corporation’s flexible response to market conditions and commitment to sustainable shareholder returns will be positively evaluated and have a favorable impact on shareholders. In discussing shareholder returns, it is important to recognize the significance of long-term growth and the strategies that support it, thereby deepening trust between the Company and its shareholders.

Overall, JTEC Corporation’s initiatives regarding shareholder returns aim to maximize shareholder value through sustainable growth and periodic reassessment of its dividend policy. Continued alignment with management strategy while advancing shareholder return measures will remain essential going forward.

Business Risks

1. Factors Causing Fluctuations in Business Performance

JTEC Corporation is highly dependent on external market conditions, customer order trends, and the specific characteristics of its products. In particular, the Company manufactures and sells high-precision X-ray mirrors for synchrotron radiation facilities, with its primary customers concentrated among research institutions and universities. As a result, changes in customers’ research plans or budget constraints can directly affect the Company’s performance.

In the Life Science & Equipment Development Business, while demand for iPS cell-related equipment and automated cell culture systems is increasing, risks include intensifying competition and technological advancements by other companies. Although demand for automation equipment has grown due to the impact of COVID-19, heightened price competition may put pressure on profit margins. The ability to respond swiftly to such changes in the competitive environment is a key factor supporting sustainable growth.

As dependence on international markets increases, foreign exchange risk cannot be overlooked. In North American and EU markets, fluctuations in the yen exchange rate directly affect sales, making currency risk management an important issue. In addition, while growth in the synchrotron-related market is anticipated, economic conditions and government research investment policies may also impact performance and must be monitored carefully.

Moreover, in long-term projects, the time lag between order receipt and revenue recognition makes earnings forecasting more challenging. Delays in specific projects may have a ripple effect on overall performance. In light of these factors, the Company must remain flexible in adapting to changes in the business environment and market needs.

2. Industry-Specific Risks

The optical products and bio-equipment manufacturing industry in which JTEC operates carries inherent risks. First, the pace of technological innovation is extremely rapid, and competition is intensifying. In fields such as nanofabrication and biotechnology, new technologies often replace older ones in a short period of time, creating a constant risk that the Company’s technologies or products may become obsolete.

In addition, the Company has a high degree of dependence on public research institutions, meaning that changes in government research budgets or policies directly affect performance. Amid uncertainty surrounding science and technology investment in Japan, maintaining international competitiveness requires sensitivity to policy trends.

The industry’s reliance on outsourced contractors also represents a significant risk factor. In the Optical Business, where extremely high precision is required, variations in quality or delivery delays by subcontractors could materially affect product quality and delivery schedules. In particular, product defects could lead to customer complaints and a decline in trust, potentially resulting in serious long-term consequences.

3. Financial and Management Risks

For JTEC Corporation, financial and management risks are particularly critical. Although recent revenues have shown an upward trend, there are situations in which debt levels and the ability to meet interest payments are scrutinized, making the maintenance of a sound financial structure an urgent priority. In the face of performance fluctuations, pressure from salary and bonus expenditures also heightens the importance of cost control.

In terms of corporate governance, a high level of compliance awareness among executives is essential to ensure transparency and maintain trust. Special attention must also be paid to the impact of subsidiaries—particularly those with overlapping directorships—on overall group performance. Optimal allocation of management resources and the maintenance of an appropriate governance structure are therefore vital.

Furthermore, financial flexibility is key when designing business strategies that anticipate future market expansion and volatility. In situations requiring long-term investment plans or financing for business expansion, interest burdens and repayment schedules may affect financial soundness. Careful financial management and the development of appropriate risk strategies are essential to maintaining stability and supporting growth.

4. Procurement and Supply Risks

Procurement and supply risks are also significant for JTEC Corporation. The manufacture of optical products and bio-equipment requires specific materials and components, and dependence on particular suppliers means that changes in supply–demand balance or price increases may affect product costs and supply capacity.

Strengthening contractual relationships with suppliers can help mitigate supply risks. Supplier selection must consider not only cost but also quality assurance and delivery reliability. In recent years, supply chain disruptions and geopolitical risks have also had an impact, requiring proactive preparedness. Diversifying and stabilizing supply systems amid intensifying competition is essential to ensuring corporate sustainability.

5. ESG-Related Risks

In recent years, risks related to Environmental (E), Social (S), and Governance (G) factors have attracted increasing attention. For JTEC Corporation, ESG initiatives influence corporate evaluation and investor decision-making, and related risks cannot be ignored. Companies are expected to demonstrate social responsibility and environmental consideration, and inadequate responses may negatively affect performance. If ESG-related issues materialize, they could damage corporate reputation and adversely affect profitability.

Moreover, as regulations become stricter, more rigorous environmental and sustainability standards may be introduced. The Company must respond promptly by incorporating ESG elements into its business strategy. Investors, in turn, must evaluate the Company’s ESG initiatives to assess sustainability and long-term growth potential.

6. Risks Associated with International Expansion

As reliance on global markets increases, risks associated with international expansion cannot be overlooked. Political risks and economic fluctuations in overseas markets may have significant impacts on business activities. Changes in trade policies or heightened geopolitical tensions could directly affect sales and profits, necessitating careful monitoring.

Additionally, cultural and legal differences across markets must be considered. In emerging markets in particular, differences in regulations and business practices may present obstacles, and flexible responses are crucial to maintaining competitiveness. Investors should closely observe how the Company formulates and executes strategies to address these international risks.

7. Natural Disaster and Geopolitical Risks

Natural disasters and geopolitical risks also represent important management concerns. Earthquakes, floods, typhoons, and other natural disasters may directly affect manufacturing processes and supply chains, potentially placing pressure on performance. Geopolitical tensions and conflicts also fall within the scope of risk.

In particular, risks in regions where key suppliers are located may affect supply capacity and, consequently, production capabilities. Strengthening risk management systems is therefore essential to prepare for such challenges.

As these risks could threaten sustainable growth, proactive countermeasures and reinforced crisis management systems are required. Investors should examine how the Company addresses these risks to assess its stability and sustainability.

JTEC Corporation must fully recognize these diverse business risks and establish comprehensive strategies to address them. By doing so, the Company can aim for sustainable growth while creating opportunities for investors to achieve adequate returns.